Advertisement

Spinal Tech

Advertisement

Saluda Medical acquired $75 million in equity financing from Boston Scientific and Redmile Group to fund the finishing stages of its Evoke evoked action compound potential-controlled, Closed-Loop Spinal Cord Stimulation System.

Advertisement